These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2290210)

  • 1. [Assessment of the biological activity of residual or recurrent neuroblastoma tumors with 131I-metaiodobenzylguanidine (MIBG) scintigraphy].
    Murashima S; Takeda K; Okuda Y; Nakagawa T; Sakurai M
    Kaku Igaku; 1990 Dec; 27(12):1393-400. PubMed ID: 2290210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
    El-Maghraby T
    Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma.
    Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
    Diagn Imaging Clin Med; 1985; 54(1):21-7. PubMed ID: 3918823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
    Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
    Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
    Hibi S; Todo S; Imashuku S; Miyazaki T
    Pediatr Radiol; 1987; 17(4):308-13. PubMed ID: 3601463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of I-131 metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma].
    Iwashita S; Nakajo M; Nakabeppu Y; Tanoue T; Yonekura R; Taguchi M; Shimabukuro K; Shinohara S; Sakata H
    Kaku Igaku; 1989 Sep; 26(9):1135-47. PubMed ID: 2810911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of neural crest tumors by 123I-MIBG scintigraphy].
    Ikekubo K; Hino M; Ootsuka H; Ito H; Yamaguchi H; Dan Y; Masui Y; Bito S; Ohta K; Saiki Y
    Kaku Igaku; 1994 Nov; 31(11):1357-64. PubMed ID: 7837704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
    Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
    Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
    Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
    Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scanning with iodine-131 MIBG in children with solid tumors: an initial appraisal.
    Hadley GP; Rabe E
    J Nucl Med; 1986 May; 27(5):620-6. PubMed ID: 3712077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
    Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
    J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 131I-meta-iodobenzylguanidine scintigraphy of neuroblastomas.
    Munkner T
    Semin Nucl Med; 1985 Apr; 15(2):154-60. PubMed ID: 4001964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [131I-MIBG-meta-iodobencylguanidine (131I-MIBG) in the study of neuroblastoma].
    Ferris J; Caballero O; Verdeguer A; Esquembre C; Castel V
    An Esp Pediatr; 1987 Mar; 26(3):164-70. PubMed ID: 3579055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
    Schwarz KB; Driver I; Lewis IJ; Taylor RE
    Br J Radiol; 1997 Jan; 70():90-2. PubMed ID: 9059302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
    Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
    Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
    Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
    Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.
    Mastrangelo R; Lasorella A; Troncone L; Rufini V; Iavarone A; Riccardi R
    J Nucl Biol Med (1991); 1991; 35(4):252-4. PubMed ID: 1823829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.
    Geatti O; Shapiro B; Sisson JC; Hutchinson RJ; Mallette S; Eyre P; Beierwaltes WH
    J Nucl Med; 1985 Jul; 26(7):736-42. PubMed ID: 4009283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
    Voûte PA; Hoefnagel CA; de Kraker J
    Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.